These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27092677)

  • 1. [Overview and perspectives of mesenchymal stem cell therapy in intensive care medicine].
    Espinoza F; Aliaga F; Crawford PL
    Rev Med Chil; 2016 Feb; 144(2):222-31. PubMed ID: 27092677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The incidences of organ dysfunction in the early resuscitation of severe sepsis and septic shock patients:a retrospective analysis].
    Wan L; Liao G; Wan X; Huang Y; Huang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):418-22. PubMed ID: 29920036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
    Walter J; Ware LB; Matthay MA
    Lancet Respir Med; 2014 Dec; 2(12):1016-26. PubMed ID: 25465643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.
    Johnson CL; Soeder Y; Dahlke MH
    Stem Cells Transl Med; 2017 Apr; 6(4):1141-1151. PubMed ID: 28186706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis.
    Lee FY; Chen KH; Wallace CG; Sung PH; Sheu JJ; Chung SY; Chen YL; Lu HI; Ko SF; Sun CK; Chiang HJ; Chang HW; Lee MS; Yip HK
    Oncotarget; 2017 Jul; 8(28):45626-45642. PubMed ID: 28484089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS.
    Seeley EJ
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):14-20. PubMed ID: 23265592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving practices in critical care and their influence on acute kidney injury.
    Wilson JG; Butcher BW; Liu KD
    Curr Opin Crit Care; 2013 Dec; 19(6):523-30. PubMed ID: 24240818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis.
    Matthay MA; Pati S; Lee JW
    Stem Cells; 2017 Feb; 35(2):316-324. PubMed ID: 27888550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.
    McIntyre LA; Moher D; Fergusson DA; Sullivan KJ; Mei SH; Lalu M; Marshall J; Mcleod M; Griffin G; Grimshaw J; Turgeon A; Avey MT; Rudnicki MA; Jazi M; Fishman J; Stewart DJ;
    PLoS One; 2016; 11(1):e0147170. PubMed ID: 26821255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice.
    Luo CJ; Zhang FJ; Zhang L; Geng YQ; Li QG; Hong Q; Fu B; Zhu F; Cui SY; Feng Z; Sun XF; Chen XM
    Shock; 2014 Feb; 41(2):123-9. PubMed ID: 24169208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome.
    Byrnes D; Masterson CH; Artigas A; Laffey JG
    Semin Respir Crit Care Med; 2021 Feb; 42(1):20-39. PubMed ID: 32767301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy for kidney injury: different options and mechanisms--mesenchymal and amniotic fluid stem cells.
    Morigi M; De Coppi P
    Nephron Exp Nephrol; 2014; 126(2):59. PubMed ID: 24854642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis.
    Silversides JA; Major E; Ferguson AJ; Mann EE; McAuley DF; Marshall JC; Blackwood B; Fan E
    Intensive Care Med; 2017 Feb; 43(2):155-170. PubMed ID: 27734109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M; Rota C; Remuzzi G
    Methods Mol Biol; 2016; 1416():89-107. PubMed ID: 27236667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units.
    Issa N; Messer J; Paganini EP
    Contrib Nephrol; 2007; 156():419-27. PubMed ID: 17464153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade.
    Fazekas B; Griffin MD
    Kidney Int; 2020 Jun; 97(6):1130-1140. PubMed ID: 32305128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic action of bone marrow-derived stem cells against acute kidney injury.
    Liu P; Feng Y; Wang Y; Zhou Y
    Life Sci; 2014 Oct; 115(1-2):1-7. PubMed ID: 25219881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.